Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
NINGBO INNO PHARMCHEM CO.,LTD. specializes in providing high-quality pharmaceutical intermediates that drive innovation in healthcare. Piroxicam-Beta-Cyclodextrin (CAS 96684-39-8) is a prime example of our contribution to the field of anti-inflammatory therapies, offering enhanced efficacy and improved drug delivery characteristics.
Piroxicam is a well-established NSAID used for its potent anti-inflammatory and analgesic properties. However, its formulation challenges, such as limited solubility, can impact its absorption and onset of action. Piroxicam-Beta-Cyclodextrin addresses these issues by forming a complex with beta-cyclodextrin. This complexation significantly enhances the solubility and stability of piroxicam, making it a superior choice as a pharmaceutical intermediate. The piroxicam beta cyclodextrin pharmaceutical intermediate is critical for formulators seeking to maximize the drug's potential.
The primary benefit of this complex is its improved pharmacokinetic profile. The enhanced absorption of piroxicam from the Piroxicam-Beta-Cyclodextrin complex leads to a faster onset of anti-inflammatory and analgesic effects. This is crucial for patients suffering from conditions like arthritis or acute inflammatory episodes, where rapid symptom relief is paramount. The piroxicam beta cyclodextrin benefits are clearly demonstrated in its ability to provide quicker therapeutic results.
Moreover, research indicates that this complex may offer a more favorable gastrointestinal safety profile compared to traditional piroxicam formulations. By modifying the drug's release and absorption, the Piroxicam-Beta-Cyclodextrin complex might reduce the direct contact time of piroxicam with the stomach lining, potentially minimizing irritation and adverse events. This focus on reduced gastrointestinal impact positions it as a valuable component within NSAID complex for pain relief research.
NINGBO INNO PHARMCHEM CO.,LTD. provides Piroxicam-Beta-Cyclodextrin (CAS 96684-39-8) for companies engaged in the development of advanced anti-inflammatory treatments. The opportunity to buy this intermediate allows for the creation of more effective and patient-friendly medications, contributing to better management of inflammatory conditions and associated pain.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
